420 Participants NeededMy employer runs this trial

TH07 + Minoxidil for Male Pattern Baldness

(MATT Trial)

EA
LH
Overseen ByLori Hebert
Age: 18 - 65
Sex: Male
Trial Phase: Phase 3
Sponsor: Triple Hair Inc
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn whether a new topical solution, TH07, can help treat androgenic alopecia in men and to learn more about its safety. Participants will be asked to apply either the TH07 solution, a standard hair growth treatment (Minoxidil 5%), or a placebo every day for 24 weeks. At the end of the study, hair growth will be compared in each group to determine which treatment is most effective at increasing hair count.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am a male between 18 and 49 years old.
I have moderate to severe male pattern baldness.
Body Mass Index (BMI) in the range of 19 to 35 kg/m2
See 4 more

Exclusion Criteria

I have used or am likely to use certain specified medicines.
I have been diagnosed with certain medical conditions.
Presence of specific hair styles such as shaved scalp, use of occlusive wig, hair extensions, non-breathable wigs
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • TH07

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Arm BExperimental Treatment1 Intervention
Group II: Arm AExperimental Treatment1 Intervention
Group III: Arm CActive Control1 Intervention
Group IV: Arm DPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Triple Hair Inc

Lead Sponsor